Leucoplasia oral

Lingen MW, Abt E, Agrawal N, et al. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017 Oct;148(10):712-27;e10.Texto completo  Resumo

Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;(7):CD001829.Texto completo  Resumo

1. Kramer IR, Lucas RB, Pindborg JJ, et al. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978 Oct;46(4):518-39. Resumo

2. Axell T, Holmstrup P, Kramer IRH, et al. International seminar on oral leukoplakia and associated lesions related to tobacco habits. Community Dent Oral Epidemiol. 1984 June;12(3):145-54.

3. Axell T, Pindborg JJ, Smith CJ, et al. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med. 1996 Feb;25(2):49-54. Resumo

4. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80. Resumo

5. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021 Nov;27(8):1862-80. Resumo

6. El-Naggar AK, Chan JKC, Grandis JR, et al, eds. WHO classification of head and neck tumours. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.

7. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):612-27.Texto completo  Resumo

8. Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018 Aug;47(7):633-40. Resumo

9. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 1986 Apr;61(4):373-81. Resumo

10. Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987 Oct;8(10):1543-48. Resumo

11. Baric JM, Altman JE, Feldman RS, et al. Influence of cigarette, pipe, and cigar smoking, removable partial dentures, and age on oral leukoplakia. Oral Surg Oral Med Oral Pathol. 1982 Oct;54(4):424-9. Resumo

12. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215. Resumo

13. Liu W, Shen XM, Liu Y, et al. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases. J Oral Pathol Med. 2011 Apr;40(4):312-6. Resumo

14. Staines K, Rogers H. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners. Br Dent J. 2017 Dec;223(9):655-661.Texto completo  Resumo

15. Poh CF, Zhang L, Lam WL, et al. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest. 2001 Apr;81(4):629-34. Resumo

16. Villa A, Celentano A, Glurich I, et al. World Workshop on Oral Medicine VII: prognostic biomarkers in oral leukoplakia: a systematic review of longitudinal studies. Oral Dis. 2019 Jun;25 Suppl 1(suppl 1):64-78.Texto completo  Resumo

17. Monteiro L, Mello FW, Warnakulasuriya S. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review. Oral Dis. 2021 Nov;27(8):1977-92. Resumo

18. Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47-62.Texto completo  Resumo

19. Kawanishi S, Hiraku Y, Pinlaor S, et al. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-mediated carcinogenesis. Biol Chem. 2006 Apr;387(4):365-72. Resumo

20. Ramos-García P, González-Moles MÁ, Warnakulasuriya S. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: a systematic review and meta-analysis. Oral Oncol. 2022 Mar;126:105734. Resumo

21. Zhang L, Rosin MP. Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med. 2001 Oct;30(9):513-20. Resumo

22. Ramos-García P, González-Moles MÁ, Ayén Á, et al. Predictive value of CCND1/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: systematic review and meta-analysis. Head Neck. 2019 Sep;41(9):3395-407. Resumo

23. Odell EW. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis. 2021 Nov;27(8):1993-2007.Texto completo  Resumo

24. Warnakulasuriya S, Reibel J, Bouquot J, et al. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008 Mar;37(3):127-33.Texto completo  Resumo

25. Thomas G, Hashibe M, Jacob BJ, et al. Risk factors for multiple oral premalignant lesions. Int J Cancer. 2003 Nov 1;107(2):285-91. Resumo

26. Dietrich T, Reichart PA, Scheifele C. Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2004 Feb;40(2):158-63. Resumo

27. Fisher MA, Bouquot JE, Shelton BJ. Assessment of risk factors for oral leukoplakia in West Virginia. Community Dent Oral Epidemiol. 2005 Feb;33(1):45-52. Resumo

28. Jaber MA, Porter SR, Scully C, et al. Role of alcohol in non-smokers and tobacco in non-drinkers in the aetiology of oral epithelial dysplasia. Int J Cancer. 1998 Jul;77(3):333-6. Resumo

29. Warnakulasuriya S, Parkkila S, Nagao T, et al. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer. J Oral Pathol Med. 2008 Mar;37(3):157-65. Resumo

30. Piscopo M, Campisi G, Colella G, et al. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia. Oral Dis. 2006 Mar;12(2):130-6. Resumo

31. Petti S, Scully C. Association between different alcoholic beverages and leukoplakia among non- to moderate-drinking adults: a matched case-control study. Eur J Cancer. 2006 Mar;42(4):521-7. Resumo

32. Maserejian NN, Joshipura KJ, Rosner BA, et al. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):774-81.Texto completo  Resumo

33. Jacob BJ, Straif K, Thomas G, et al. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004 Aug;40(7):697-704. Resumo

34. Yen AM, Chen SC, Chang SH, et al. The effect of betel quid and cigarette on multistate progression of oral pre-malignancy. J Oral Pathol Med. 2008 Aug;37(7):417-22. Resumo

35. Ariyawardana A, Sitheeque MA, Ranasinghe AW, et al. Prevalence of oral cancer and pre-cancer and associated risk factors among tea estate workers in central Sri Lanka. J Oral Pathol Med. 2007 Nov;36(10):581-7. Resumo

36. Takeshima M, Saitoh M, Kusano K, et al. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka. J Oral Pathol Med. 2008 Sept;37(8):475-9. Resumo

37. Hsieh CH, Chang JW, Hsieh JJ, et al. Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck. 2011 Dec;33(12):1758-64. Resumo

38. Krogh P, Holmstrup P, Thorn JJ, et al. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):48-54. Resumo

39. Krogh P, Holmstrup P, Vedtofte P, et al. Yeast organisms associated with human oral leukoplakia. Acta Derm Venereol Suppl (Stockh). 1986 Jan;63(1):51-5. Resumo

40. Holmstrup P, Bessermann M. Clinical, therapeutic, and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol. 1983 Oct;56(4):388-95. Resumo

41. Barrett AW, Kingsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis. 1998 Mar;4(1):26-31. Resumo

42. Majumder M, Sikdar N, Paul RR, et al. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among workers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol Biomarkers Prev. 2005 Sept;14(9):2106-12.Texto completo  Resumo

43. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):582-590.Texto completo  Resumo

44. King GN, Healy CM, Glover MT, et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol. 1994 Dec;78(6):718-26. Resumo

45. Hernandez G, Arriba L, Jimenez C, et al. Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol. 2003 Jan;39(1):87-90. Resumo

46. Alter B. Aplastic anemia, pediatric aspects. Oncologist. 1996;1(6):361-6.Texto completo  Resumo

47. Grein Cavalcanti L, Lyko KF, Araújo RL, et al. Oral leukoplakia in patients with Fanconi anaemia without hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2015 Jun;62(6):1024-6. Resumo

48. Tekcicek M, Tavil B, Cakar A, et al. Oral and dental findings in children with Fanconi anemia. Pediatr Dent. 2007 May-Jun;29(3):248-52. Resumo

49. Hakansson N, Floderus B, Gustavsson P, et al. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology. 2001 Sept;12(5):552-7. Resumo

50. Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer. 2003 Jun 2;88(11):1702-7.Texto completo  Resumo

51. Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996 Jul;7(4):458-63. Resumo

52. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000 Dec;28(12):922-7. Resumo

53. Sand L, Jalouli J, Larsson PA, et al. Human papilloma viruses in oral lesions. Anticancer Res. 2000 Mar-Apr;20(2B):1183-8. Resumo

54. Cianfriglia F, Di Gregorio DA, Cianfriglia C, et al. Incidence of human papillomavirus infection in oral leukoplakia: indications for a viral aetiology. J Exp Clin Cancer Res. 2006 Mar;25(1):21-8. Resumo

55. Dickenson AJ, Currie WJ, Avery BS. Screening for syphilis in patients with carcinoma of the tongue. Br J Oral Maxillofac Surg. 1995 Oct;33(5):319-20. Resumo

56. Michalek AM, Mahoney MC, McLaughlin CC, et al. Historical and contemporary correlates of syphilis and cancer. Int J Epidemiol. 1994 Apr;23(2):381-5. Resumo

57. Petti S, Scully C. The role of the dental team in preventing and diagnosing oral cancer: 5. Alcohol and the role of the dentist in alcohol cessation. Dent Update. 2005 Oct;32(8):454-5, 458-60, 462. Resumo

58. Shiu MN, Chen TH. Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev. 2004 Feb;13(1):39-45. Resumo

59. Sankaranarayanan R, Fernandez Garrote L, Lence Anta J, et al. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncol. 2002 Feb;38(2):131-6. Resumo

60. Shugars DC, Patton LL. Detecting, diagnosing, and preventing oral cancer. Nurse Pract 1997 Jun;22(6):105;109-10;113-5. Resumo

61. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer. 1975 Oct;36(4):1386-92. Resumo

62. Wright JM. Oral precancerous lesions and conditions. Semin Dermatol. 1994 Jun;13(2):125-31. Resumo

63. Jaber MA, Porter SR, Gilthorpe MS, et al. Risk factors for oral epithelial dysplasia - the role of smoking and alcohol. Oral Oncol. 1999 Mar;35(2):151-6. Resumo

64. Sankaranarayanan R. Screening for cervical and oral cancers in India is feasible and effective. Natl Med J India. 2005 Nov-Dec;18(6):281-4. Resumo

65. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin. 1995 Nov-Dec;45(6):328-51.Texto completo  Resumo

66. Quah SR, Cockerham WC, eds. ​International encyclopedia of public health. 2nd ed. Oxford: Elsevier; 2017.

67. Liu W, Wang YF, Zhou HW, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010 Dec 16;10:685.Texto completo  Resumo

68. Yanik EL, Katki HA, Silverberg MJ, et al. Leukoplakia, oral cavity cancer risk, and cancer survival in the US elderly. Cancer Prev Res (Phila). 2015 Sept;8(9):857-63. Resumo

69. Massano J, Regateiro FS, Januario G, et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):67-76. Resumo

70. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953 Sept;6(5):963-8. Resumo

71. Braakhuis BJ, Brakenhoff RH, Leemans CR. Head and neck cancer: molecular carcinogenesis. Ann Oncol. 2005;16(suppl 2):ii249-50.Texto completo  Resumo

72. Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol. 2005 Apr;15(2):113-20. Resumo

73. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res. 2004 Jun 1;10(11):3607-13.Texto completo  Resumo

74. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003 Apr 16;63(8):1727-30.Texto completo  Resumo

75. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sept;17(3):691-4. Resumo

76. Silverman S Jr. Early diagnosis of oral cancer. Cancer. 1988 Oct 15;62(suppl 8):1796-9. Resumo

77. Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988 Oct;156(4):273-5. Resumo

78. Scully C, Malamos D, Levers BG, et al. Sources and patterns of referrals of oral cancer: role of general practitioners. Br Med J (Clin Res Ed). 1986 Sept 6;293(6547):599-601.Texto completo  Resumo

79. Dimitroulis G, Reade P, Wiesenfeld D. Referral patterns of patients with oral squamous cell carcinoma, Australia. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):23-7. Resumo

80. Chiesa F, Sala L, Costa L, et al. Excision of oral leukoplakias by CO2 laser on an outpatient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori. 1986 Jun 30;72(3):307-12. Resumo

81. Holmstrup P, Vedtofte P, Reibel J, et al. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007 May;36(5):262-6. Resumo

82. Califano J, Westra WH, Meininger G, et al. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res. 2000 Feb;6(2):347-52.Texto completo  Resumo

83. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):188-91. Resumo

84. Karabulut A, Reibel J, Therkildsen MH, et al. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995 May;24(5):198-200. Resumo

85. Fischer DJ, Epstein JB, Morton TH, et al. Interobserver reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med. 2004 Feb;33(2):65-70. Resumo

86. Fischer DJ, Epstein JB, Morton TH Jr, et al. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol. 2005 May;41(5):489-96. Resumo

87. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006 Mar;42(3):229-39. Resumo

88. Lathanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. Quintessence Int. 2007 Sept;38(8):e448-55. Resumo

89. Odell E, Kujan O, Warnakulasuriya S, et al. Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis. 2021 Nov;27(8):1947-76. Resumo

90. Kuffer R, Lombardi T. Premalignant lesions of the oral mucosa: a discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncol. 2002 Feb;38(2):125-30. Resumo

91. Rethman M, Carpenter W, Cohen EE, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010 May;14(5):509-20. Resumo

92. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009 Jan 30;1:5.Texto completo  Resumo

93. Lingen MW, Abt E, Agrawal N, et al. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017 Oct;148(10):712-27;e10.Texto completo  Resumo

94. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions: computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc. 1999 Oct;130(10):1445-57. Resumo

95. Scheifele C, Schmidt-Westhausen A, Dietrich T, et al. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol. 2004 Sept;40(8):824-8. Resumo

96. Svirsky JA, Burns JC, Carpenter WM, et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent. 2002 Nov-Dec;50(6):500-3. Resumo

97. Kosicki DM, Riva C, Pajarola GF, et al. Oral CDx brush biopsy - a tool for early diagnosis of oral squamous cell carcinoma [in German]. Schweiz Monatsschr Zahnmed. 2007;117(3):222-7. Resumo

98. Poate TW, Buchanan JA, Hodgson TA, et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol. 2004 Sept;40(8):829-34. Resumo

99. Remmerbach TW, Weidenbach H, Hemprich A, et al. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases. Anal Cell Pathol. 2003;25(4):159-66. Resumo

100. Potter TJ, Summerlin DJ, Campbell JH. Oral malignancies associated with negative transepithelial brush biopsy. J Oral Maxillofac Surg. 2003 Jun;61(6):674-7. Resumo

101. Scheifele C, Schlechte H, Bethke G, et al. Detection of TP53-mutations in brush biopsies from oral leukoplakias [in German]. Mund Kiefer Gesichtschir. 2002 Nov;6(6):410-4. Resumo

102. Remmerbach TW, Mathes SN, Weidenbach H, et al. Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas [in German]. Mund Kiefer Gesichtschir. 2004 Jul;8(4):229-36. Resumo

103. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med. 2004 Aug;33(7):398-404. Resumo

104. Remmerbach TW, Weidenbach H, Muller C, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol. 2003;25(3):139-46. Resumo

105. Jayasinghe RD, Hettiarachchi PVKS, Amugoda D, et al. Validity of toluidine blue test as a diagnostic tool for high risk oral potentially malignant disorders - a multicentre study in Sri Lanka. J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):547-51.Texto completo  Resumo

106. Swinson B, Jerjes W, El-Maaytah M, et al. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol. 2006 Mar;42(3):221-8. Resumo

107. Suhr MA, Hopper C, Jones L, et al. Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer. Int J Oral Maxillofac Surg. 2000 Dec;29(6):453-7. Resumo

108. Sharwani A, Jerjes W, Salih V, et al. Assessment of oral premalignancy using elastic scattering spectroscopy. Oral Oncol. 2006 Apr;42(4):343-9. Resumo

109. Awan KH, Morgan PR, Warnakulasuriya S. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med. 2011 Aug;40(7):541-4. Resumo

110. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011 Apr;47(4):274-7. Resumo

111. Mendonca P, Sunny SP, Mohan U, et al. Non-invasive imaging of oral potentially malignant and malignant lesions: a systematic review and meta-analysis. Oral Oncol. 2022 Jul;130:105877. Resumo

112. Westra WH, Sidransky D. Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin Cancer Res. 2006 Nov 15;12(22):6594-7.Texto completo  Resumo

113. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000 Feb;6(2):357-62.Texto completo  Resumo

114. Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007 Mar;65(3):424-6. Resumo

115. Epstein JB, Gorsky M, Lonky S, et al. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dentist. 2006 Jul-Aug;26(4):171-4. Resumo

116. Lane PM, Gilhuly T, Whitehead P, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006 Mar-Apr;11(2):024006. Resumo

117. Poh CF, Ng SP, Williams PM, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007 Jan;29(1):71-6. Resumo

118. Poh CF, Zhang L, Anderson DW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res. 2006 Nov 15;12(22):6716-22.Texto completo  Resumo

119. Tatehara S, Sato T, Takebe Y, et al. Photodynamic diagnosis using 5-aminolevulinic acid with a novel compact system and chromaticity analysis for the detection of oral Ccancer and high-risk potentially malignant oral disorders. Diagnostics (Basel). 2022 Jun 23;12(7):1532.Texto completo  Resumo

120. Zhang L, Cheung KJ Jr, Lam WL, et al. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer. 2001 Jun 1;91(11):2148-55. Resumo

121. de Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, et al. Podoplanin expression in oral leukoplakia: tumorigenic role. Oral Oncol. 2013 Jun;49(6):598-603. Resumo

122. Patel V, Leethanakul C, Gutkind JS. New approaches to the understanding of the molecular basis of oral cancer. Crit Rev Oral Biol Med. 2001;12(1):55-63. Resumo

123. Khanna R, Agarwal A, Khanna S, et al. S-phase fraction and DNA ploidy in oral leukoplakia. ANZ J Surg. 2010m Jul-Aug;80(7-8):548-51. Resumo

124. Liu W, Zheng W, Xie J, et al. Identification of genes related to carcinogenesis of oral leukoplakia by oligo cancer microarray analysis. Oncol Rep. 2011 Jul;26(1):265-74. Resumo

125. Sivadasan P, Gupta MK, Sathe G, et al. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. J Proteomics. 2020 Feb 10;212:103574. Resumo

126. Franzmann EJ, Donovan MJ. Effective early detection of oral cancer using a simple and inexpensive point of care device in oral rinses. Expert Rev Mol Diagn. 2018 Oct;18(10):837-44. Resumo

127. Goldoni R, Scolaro A, Boccalari E, et al. Malignancies and biosensors: a focus on oral cancer detection through salivary biomarkers. Biosensors (Basel). 2021 Oct 15;11(10):396.Texto completo  Resumo

128. Kramer IR. Oral leukoplakia. J R Soc Med. 1980 Nov;73(11):765-7.Texto completo  Resumo

129. Pindborg JJ, Roed-Petersen B, Renstrup G. Role of smoking in floor of mouth leukoplakias. J Oral Pathol. 1972;1(1):22-9. Resumo

130. Ramos-García P, González-Moles MÁ, Mello FW, et al. Malignant transformation of oral proliferative verrucous leukoplakia: a systematic review and meta-analysis. Oral Dis. 2021 Nov;27(8):1896-907. Resumo

131. Vázquez-Álvarez R, Fernández-González F, Gándara-Vila P, et al. Correlation between clinical and pathologic diagnosis in oral leukoplakia in 54 patients. Med Oral Patol Oral Cir Bucal. 2010 Nov 1;15(6):e832-8.Texto completo  Resumo

132. Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med. 1969 Jun;62(6):610-4.Texto completo  Resumo

133. Ramos-García P, González-Moles MÁ, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis. 2021 Nov;27(8):1919-35. Resumo

134. Lopez-Labady J, Viaalrroel-Dorrego M, Gonzalez N, et al. Oral manifestations of systemic and cutaneous lupus erythematosus in a Venezuelan population. J Oral Pathol Med. 2007 Oct;36(9):524-7. Resumo

135. Burge SM, Frith PA, Juniper RP, et al. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol. 1989 Dec;121(6):727-41. Resumo

136. Karjalainen TK, Tomich CE. A histopathologic study of oral mucosal lupus erythematosus. Oral Surg Oral Med Oral Pathol. 1989 May;67(5):547-54. Resumo

137. Serpico R, Pannone G, Santoro A, et al. Report of a case of discoid lupus erythematosus localized to the oral cavity: immunofluorescence findings. Int J Immunopathol Pharmacol. 2007 Jul-Sept;20(3):651-3. Resumo

138. van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol. 2002 Sept;38(6):521-6. Resumo

139. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008 Feb;37(2):63-9. Resumo

140. Schepman KP, van der Meij EH, Smeele LE, et al. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 1998 Jul;34(4):270-5. Resumo

141. Saito T, Sugiura C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg. 2001 Feb;30(1):49-53. Resumo

142. Mehanna HM, Rattay T, Smith J, et al. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 2009 Dec;31(12):1600-9. Resumo

143. Kuribayashi Y, Tsushima F, Sato M, et al. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 2012 Oct;41(9):682-8. Resumo

144. Sundberg J, Korytowska M, Holmberg E, et al. Recurrence rates after surgical removal of oral leukoplakia - a prospective longitudinal multi-centre study. PLoS One. 2019;14(12):e0225682.Texto completo  Resumo

145. Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016 Jul 29;(7):CD001829.Texto completo  Resumo

146. Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006 May;42(5):461-74. Resumo

147. Girard KR, Strahs GR, Chung B. Panoral verrucous dysplasia: report of a case treated with split-thickness skin graft. Oral Surg Oral Med Oral Pathol. 1980 Aug;50(2):124-6. Resumo

148. Bagan JV, Jiménez-Soriano Y, Diaz-Fernandez JM, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Oral Oncol. 2011 Aug;47(8):732-5. Resumo

149. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986 Dec 11;315(24):1501-5. Resumo

150. Sankaranarayanan R, Mathew B, Varghese C. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol.1997 Jul;33(4):231-6. Resumo

151. Stich HF, Hornby AP, Mathew B, et al. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett. 1988 May;40(1):93-101. Resumo

152. Elad S, Epstein JB, von Bültzingslöwen I, et al. Topical immunomodulators for management of oral mucosal conditions, a systematic review. Part II: miscellaneous agents. Expert Opin Emerg Drugs. 2011 Mar;16(1):183-202. Resumo

153. Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6(2):147-60. Resumo

154. Scully C, Cawson RA. Potentially malignant oral lesions. J Epidemiol Biostat. 1996;1:3-12.

155. Chang JC, Distler SG, Kaplan AM. Tobacco smoke suppresses T cells but not antigen-presenting cells in the lung-associated lymph nodes. Toxicol Appl Pharmacol. 1990 Mar 1;102(3):514-23. Resumo

156. Sciubba JJ, Helman JI. Current management strategies for verrucous hyperkeratosis and verrucous carcinoma. Oral Maxillofac Surg Clin North Am. 2013 Feb;25(1):77-82. Resumo

157. Feller L, Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int J Dent. 2012;2012:540561.Texto completo  Resumo

158. Warnakulasuriya S, Kovacevic T, Madden P, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011 Oct;40(9):677-83. Resumo

159. Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: systematic review and meta-analysis of the last 5 years. Oral Dis. 2021 Nov;27(8):1881-95. Resumo